Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies

Bispecific T cell engagers (BiTEs) are an innovative class of immunotherapeutics that redirect T cells to tumor surface antigens. While efficacious against certain hematological malignancies, limited bioavailability and severe toxicities have so far hampered broader clinical application, especially...

Descripción completa

Detalles Bibliográficos
Autores principales: Heidbuechel, Johannes P. W., Engeland, Christine E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052795/
https://www.ncbi.nlm.nih.gov/pubmed/33863363
http://dx.doi.org/10.1186/s13045-021-01075-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052795/
https://www.ncbi.nlm.nih.gov/pubmed/33863363
http://dx.doi.org/10.1186/s13045-021-01075-5

Ejemplares similares